Cardiorenal syndrome
- PMID: 19007588
- DOI: 10.1016/j.jacc.2008.07.051
Cardiorenal syndrome
Abstract
The term cardiorenal syndrome (CRS) increasingly has been used without a consistent or well-accepted definition. To include the vast array of interrelated derangements, and to stress the bidirectional nature of heart-kidney interactions, we present a new classification of the CRS with 5 subtypes that reflect the pathophysiology, the time-frame, and the nature of concomitant cardiac and renal dysfunction. CRS can be generally defined as a pathophysiologic disorder of the heart and kidneys whereby acute or chronic dysfunction of 1 organ may induce acute or chronic dysfunction of the other. Type 1 CRS reflects an abrupt worsening of cardiac function (e.g., acute cardiogenic shock or decompensated congestive heart failure) leading to acute kidney injury. Type 2 CRS comprises chronic abnormalities in cardiac function (e.g., chronic congestive heart failure) causing progressive chronic kidney disease. Type 3 CRS consists of an abrupt worsening of renal function (e.g., acute kidney ischemia or glomerulonephritis) causing acute cardiac dysfunction (e.g., heart failure, arrhythmia, ischemia). Type 4 CRS describes a state of chronic kidney disease (e.g., chronic glomerular disease) contributing to decreased cardiac function, cardiac hypertrophy, and/or increased risk of adverse cardiovascular events. Type 5 CRS reflects a systemic condition (e.g., sepsis) causing both cardiac and renal dysfunction. Biomarkers can contribute to an early diagnosis of CRS and to a timely therapeutic intervention. The use of this classification can help physicians characterize groups of patients, provides the rationale for specific management strategies, and allows the design of future clinical trials with more accurate selection and stratification of the population under investigation.
Comment in
-
The cardiorenal syndrome a classification into 4 groups?J Am Coll Cardiol. 2009 Apr 14;53(15):1340; author reply 1340-1. doi: 10.1016/j.jacc.2008.12.042. J Am Coll Cardiol. 2009. PMID: 19358954 No abstract available.
-
Cardiorenal Syndrome in End-Stage Kidney Disease.Blood Purif. 2015;40(4):337-43. doi: 10.1159/000441583. Epub 2015 Nov 17. Blood Purif. 2015. PMID: 26657922
Similar articles
-
[Cardiorenal syndrome, current understanding].Recenti Prog Med. 2009 Apr;100(4):202-13. Recenti Prog Med. 2009. PMID: 19554920 Review. Italian.
-
The cardiorenal syndrome.Blood Purif. 2009;27(1):114-26. doi: 10.1159/000167018. Epub 2009 Jan 23. Blood Purif. 2009. PMID: 19169027 Review.
-
Volume overload and cardiorenal syndromes.Congest Heart Fail. 2010 Jul;16 Suppl 1:Si-iv; quiz Svi. doi: 10.1111/j.1751-7133.2010.00176.x. Congest Heart Fail. 2010. PMID: 20653717
-
Cardiorenal syndromes: definition and classification.Contrib Nephrol. 2010;164:33-38. doi: 10.1159/000313718. Epub 2010 Apr 20. Contrib Nephrol. 2010. PMID: 20427991 Review.
-
[Cardiorenal syndromes].Orv Hetil. 2011 Sep 18;152(38):1520-7. doi: 10.1556/OH.2011.29212. Orv Hetil. 2011. PMID: 21896443 Review. Hungarian.
Cited by
-
Influence of chronic kidney disease on cardiac structure and function.Curr Hypertens Rep. 2015 Sep;17(9):581. doi: 10.1007/s11906-015-0581-x. Curr Hypertens Rep. 2015. PMID: 26194332 Review.
-
Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy.Diabetes Ther. 2024 Oct;15(10):2153-2182. doi: 10.1007/s13300-024-01641-3. Epub 2024 Aug 21. Diabetes Ther. 2024. PMID: 39167303 Free PMC article. Review.
-
A brand-new cardiorenal syndrome in the COVID-19 setting.Clin Kidney J. 2020 Jun 4;13(3):291-296. doi: 10.1093/ckj/sfaa082. eCollection 2020 Jun. Clin Kidney J. 2020. PMID: 32695320 Free PMC article. Review.
-
Uremic toxins in chronic kidney disease highlight a fundamental gap in understanding their detrimental effects on cardiac electrophysiology and arrhythmogenesis.Acta Physiol (Oxf). 2022 Nov;236(3):e13888. doi: 10.1111/apha.13888. Epub 2022 Oct 1. Acta Physiol (Oxf). 2022. PMID: 36148604 Free PMC article. Review.
-
Expression, Functional Polymorphism, and Diagnostic Values of MIAT rs2331291 and H19 rs217727 Long Non-Coding RNAs in Cerebral Ischemic Stroke Egyptian Patients.Int J Mol Sci. 2024 Jan 10;25(2):842. doi: 10.3390/ijms25020842. Int J Mol Sci. 2024. PMID: 38255915 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical